Recently, fibrillin-1 (FBN1) was reported to play an important role in maintaining the physiological arterial stiffness of essential hypertension (EH). Here, we designed a two-stage case-control study to investigate whether the FBN1 gene harbored any genetic variations associated with EH.
Elastic fibers are critical for the mechanical properties of normal blood vessel wall and consist of elastin, fibrillin, and other protein components. 1 Fibrillin-1 (FBN1), a component of elastic fibers, links smooth muscle cells to the elastic lamellae and functions as a skeleton for the deposition of tropoelastin, provides both load-bearing and anchoring functions within the arterial wall. 2 Elastin and fibrillin can act as signal transducers and regulate cellular proliferation, migration, extracellular matrix adaption, and degradation, with a key role in the maintenance of the physiological structure and function of the blood vessels. 3 Furthermore, a quantitative or qualitative alteration in elastic fibers during embryonic development and early infancy may lead to defective elastic fibers in vessel wall which would constitute the basis of the large vessels compliance reduction in adulthood. 1 This alteration produces less efficient elastic fibers and altered signaling to smooth muscle cells, and in turn to abnormal wall architecture and mechanical properties. 4 As well known, the structural and mechanical abnormalities of the blood vessel leading to large artery stiffening and vascular remodeling are two of the key features associated with essential hypertension (EH). 5 Series studies reported that some genetic defects of elastic fibers components are accompanied by abnormal vessel structure and hypertension. 1, 6, 7 Significantly, FBN1 is the gene affected in Marfan syndrome, in which large artery stiffening and elevated pulse pressure are the main determinants of aortic dilation. 8 On the other hand, study reported that there was an association between systolic blood pressure (SBP) and (TAAAA)n repeat of variable nucleotide tandem repeats in the FBN1 gene. 9 In addition, Medley reported that FBN1 genotype is associated with aortic stiffness in patients with coronary artery disease. 10 Therefore, we assumed that genetic variations of the FBN1 gene might contribute to the development or progression of human EH. Accordingly, these findings suggest that genetic variations in the genes of elastic fibers components should be explored as causative elements in the development of EH. 6 
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FBN1 Gene Associated With Hypertension in Chinese
In this study, we designed a two-stage study, which could provide near-optimal power to detect the true marker conferring disease risk while substantially reducing the total number of marker evaluations, 12, 13 to investigate the association of FBN1 gene with EH in northern Han Chinese population.
Methods subjects
All the subjects were recruited from the International Collaborative Study of Cardiovascular Disease in Asia (InterASIA in China). InterASIA used a four-stage stratified sampling method to select a nationally representative sample of the general population aged 35-74 years in China. A total of 15,838 persons accepted the informed consent and completed the survey and examinations. 14 In this study, we enrolled 1,317 hypertensives (655 men and 662 women) with SBP ≥150 mm Hg, diastolic blood pressure (DBP) ≥95 mm Hg, or current use of antihypertensive medication and 1,269 healthy normotensives (658 men and 611 women) with SBP <140 mm Hg and DBP <90 mm Hg from the northern field centers of InterASIA, namely, Beijing, Jilin, Shandong, and Shannxi. These total 2,586 subjects were unrelated and taken as the main study population in this study.
In this study, we conducted a two-stage case-control study to screen and verify susceptible single-nucleotide polymorphisms (SNPs) to EH. From the main study population, we selected 993 subjects as a subsample containing 503 hypertensive patients (SBP ≥160 mm Hg and/or DBP ≥100 mm Hg) and 490 age group-(5 years) and gender-matched normotensive controls (SBP <140 mm Hg and DBP <90 mm Hg) for the stage 1 study. The criterion for case selection of the subsample was based on the hypothesis that individuals with higher BP were likely to be enriched for genetic susceptibility, which might increase the difference in frequency of susceptibility alleles between cases and controls to improve power. In stage 2, the remaining individuals included 814 hypertensive cases with SBP ≥150 mm Hg and/or DBP ≥95 mm Hg) or current use of antihypertensive medication and 779 age group-(5 years-) and gender-matched normotensives (SBP <140 mm Hg and DBP <90 mm Hg). Initial associations found in stage 1 were taken as hypotheses that were further tested in the subsample stage 2. Finally, we performed meta-analysis to estimate the ORs and P values in the combined sample. In addition, genomic control analysis revealed no evidence of population stratification with this data in previous study. 15 During clinic or home visits, trained research staff administered a standard questionnaire. They obtained information on demographic characteristics including age, gender, ethnicity, education, occupation, and household income. The interview also included questions related to the diagnosis and treatment of hypertension. 16 Three BP measurements were obtained from each participant by trained and certified observers according to a standard protocol recommended by the American Heart Association. 17 BP was measured with the participant in the sitting position after 5 min of rest. In addition, participants were advised to avoid alcohol, cigarette smoking, coffee, or tea, and exercise for at least 30 min before their BP measurements. Subjects with a clinical history of secondary hypertension, coronary heart disease, diabetes, and chronic kidney disease were excluded from the study.
snPs selection
The FBN1 gene is located on chromosome 15 at q21.1 and spans 240,414 basepairs with 66 exons. We searched the SNPs with minor allele frequency ≥0.05 from HapMap of Han Chinese in Beijing, China (CHB) (dbSNP, build128; available at http://www.ncbi.nlm.nih.gov/SNP/; last accessed 25 June 2007) and applied a functional candidate strategy to search functional SNPs with the role of transcription, regulating, or splicing, etc. and other SNPs which was reported to be associated with coronary artery disease. 10 Six SNPs were selected and located in putative functional regions of the gene, e.g., exons, promoter/regulatory region, transcript factor banding site or splicing regulation (see Supplementary Table S1 ). Rs6493333 and rs6493334 was located in 5′flanking promoter/regulatory region, rs25457 in exon 16, rs140598 in exon 28, rs11853943 in intron 28, and rs363831 in exon 57.
genotyping
Blood for genotyping was taken into EDTA-containing receptacles; DNA was extracted according to a standard phenolchloroform method 18 and stored at −20 °C until required for batch genotyping. All SNPs were genotyped according to PCR and restriction fragment length polymorphism methods (PCR-RFLP). The primers, related restriction endonuclease and recognized alleles are shown in Table 1 . Digested fragments were separated by electrophoresis in 3% agarose gel and identified by ethidium bromide staining. Ninety-six randomly selected individuals were genotyped again for quality control with complete concordance and genotyping was done blindly to the case-control status in Chinese National Human Genome Center, Beijing.
statistical analysis
Unpaired Student's t-test was used to test the differences of all measured variables presented as the means ± s.d. between cases and controls. Qualitative variables and the frequencies of the alleles and genotypes between cases and controls were compared by the χ 2 test. Multivariate unconditional logistic regression was applied to adjust for covariates including age, gender, body mass index, glucose, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, creatinine, smoking, and drinking status. The probability for stepwise entry is 0.05 and that for stepwise removal is 0.1. The criterion for SNPs entering into stage 2 study was that the SNPs had a two-tailed probability (P) value of <0.05 for the comparisons of allele or genotype frequencies distributions between cases and controls in stage 1. Bonferroni correction for multiple comparisons wasn't used in stage 1 because stage 1 served for hypothesis generation. Statistical analyses were performed with Statistical Product and Service Solutions 13.0 (SPSS, Chicago, IL).
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In stage 2, replication association analysis was performed and meta-analysis further proceeded, which take advantage of the high accuracy of effect size and increase statistical power. 19 Random effect model, which may well be conservative compared with a fixed effects model when the primary goal is hypothesis testing, was selected and inverse-variance method was employed to estimate combined odds ratio (OR) and its 95% confidence interval (CI) after adjusting for covariates. The two-sided Z-test with the corresponding P value were summed across two studies weighting them by the per study sample size to test the significance of single SNP in joint study. We assessed heterogeneity among study populations with the P value of the Cochran's Q-statistic for test of heterogeneity and I 2 statistic which measures the proportion of total variance in estimated ORs due to heterogeneity. A value of the I 2 statistic >50% indicates the high degree of heterogeneity in estimated ORs across study populations. 20 The statistics of meta-analysis were calculated in the STATA software package (College Station, TX).
Furthermore, the quantitative trait of blood pressure was compared between genotypes by one-way ANOVA and multifactorial variance analysis adjusted for covariates in nontreatment hypertensive patients and controls.
Hardy-Weinberg equilibrium (HWE) was assessed by Fisher's exact χ 2 test using the program HWE. 21 To test the associations of statistically inferred haplotypes with EH, we used the Haplo. score with R software (http://cran.r-project.org/) as outlined by Schaid et al. 22 The method models an individual's phenotype as a function of each inferred haplotype, weighted with their estimated probability, to account for haplotype ambiguity.
To obtain the ORs of risk haplotypes, the Haplo.glm approach was performed. 23 Both Haplo.score and Haplo.glm were implemented in the Haplo.stats package, a suite of R routines for the analysis of indirectly measured haplotypes. A diplotype analysis was then followed by using a weighted logistic regression, with the weights being the probability for each possible haplotype pair combination for an individual as estimated by Haplo.em. Only the haplotypes and diplotypes with frequency >5% were considered for the haplotype and diplotype analyses. Table 1 showed the characteristics of subjects included in the stage 1, stage 2, and joint analysis. Age and the percentage of men were not significantly different between cases and controls. The cases generally had lower high-density lipoprotein cholesterol and higher body mass index, total cholesterol, triglycerides, and glucose levels than that in controls. There were no significant differences in the prevalence of drinking and smoking between cases and controls. As expected, the SBP and DBP levels were both significantly higher in the cases of stage 1 than those of stage 2 (both P values <0.0001).
single locus analyses
In stage 1, out of six selected SNPs, four were common (minor allele frequency ≥0.05) and analyzed. BMI, body mass index; Cr, creatinine; DBP, diastolic blood pressure; Glu, glucose; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides. *P < 0.0001 for comparison with corresponding controls; **P < 0.001 for comparison with corresponding controls; ***P < 0.01 for comparison with corresponding controls; † P < 0.05 for comparison with corresponding controls; † † P < 0.0001 for comparison with corresponding variables in stage 2.
original contributions
FBN1 Gene Associated With Hypertension in Chinese
additive and dominant models of rs140598 and rs649333 presented statistical correlations with hypertension. After adjusted for the covariates, including age, gender, body mass index, glucose, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, creatinine, smoking and drinking status, the associations of rs140598 and rs6493333 with EH were still statistically significant. In stage 2 sample, rs140598, but not rs649333, presented significant association with hypertension, P value was 0.028 for allele and after adjusted for covariates, P values were 0.038, 0.140, and 0.052 for additive, dominant and recessive model respectively. Meta-analysis results from random effect model showed that genetic variance of rs140598 in the two-stage samples presented well homogeneity (I 2 = 0), Allele and additive, dominant, and recessive model presented statistical significance for EH after adjusted for covariates. Rs6493333 contributed significant heterogeneity to the two stage samples and didn't presented statistical association with EH. The P values of twosided Z score test and Cochran's Q test, I 2 statistic and combined ORs (95%CI) were listed in Table 3 .
Direct joint analysis, which has been reported as superior to independent analyses for replication study, 24, 25 was performed in the main study population of the sample of 1,317 cases and 1,269 controls and results showed obviously similar to those of meta-analysis above. But the ORs of rs140598 were higher than that of meta-analysis and even closer to 1 (see Supplementary  Table S2 ). Haplotypes were constructed by the two SNPs arranged in the order of rs140598 and rs6493333. Three haplotypes constructed by the two SNPs had the frequencies over 0.05 and accounted for 98.8% haplotype variations ( Table 4) . With Hap1 (C-C) used as reference, the frequency of Hap2 (G-C) which carried rs140598 G protective alleles, was significantly lower in the cases than in the controls, adjusted OR (95% CI) was 0.823 (0.715-0.948), P = 0.006. Similarly, diplotype analyses showed that compared with Dip1 (Hap1-Hap1), the adjusted OR for Dip4 (Hap2-Hap2) was 0.619 (95% CI, 0.436-0.880; P = 0.008). But no significant interaction of genotype, haplotype or diplotype, and smoking or drinking was found for EH (all P values >0.1).
Blood pressure comparison analysis
The results of one-way ANOVA indicated that there was a linear progressively decreasing of SBP (P = 0.018) but not DBP (P = 0.230) for genotype CC-CG-GG in nontreatment hypertensive patients and controls. Furthermore, multifactorial variance analysis was used to adjust for covariates and results still presented statistical significance for SBP (P = 0.047) whereas not for DBP (P = 0.522) ( Table 5) . discussion FBN1 gene is located on 15q21.1 in human and the encoded protein of this gene serve as a structural component of 10-12 nm calcium-binding microfibrils. These microfibrils provide force bearing structural support in elastic and nonelastic connective tissue throughout the body. In vascular tissue, fibrillins are large glycoproteins that polymerize into microfibrils that associate with elastin and other elastic fiber proteins. Mutation of FBN1 gene has been reported as having an important role in cardiovascular risk associated with Marfan syndrome resulting in aortic dilatation and dissection, 26 artery stiffening, isolated ectopia lentis, autosomal dominant Weill-Marchesani syndrome, 10, 27 etc. Recent studies further demonstrated that FBN1 had both differential and complementary roles in arterial wall formation and function. 1, 28 Therefore, the contribution of FBN1 to the pathogenesis of vascular defects in human hypertension would deserve further investigation and that would advance our knowledge of the structural determinants of vascular physiology and disease. 28 So far, the association of the variation in the FBN1 gene with hypertension has not been explored. In this study, we employed a two-stage approach and selected six functional candidate SNPs to assess the association between the FBN1 gene and EH in north Han Chinese population. The has lower minor allele frequency 0.12 in controls and the power for OR equal to 1.3 is 90.66%. Furthermore, we conducted a meta-analysis to assess heterogeneity among study populations with the P value of the Q-statistic for test of heterogeneity and I 2 statistic which measures the proportion of total variance in estimated ORs due to heterogeneity. Meta-analysis, which due to increased power and validation, may provide more robust risk estimates and its 95% CI from direct joint analysis. 19, 20 In results, the SNPs of rs140598 and rs6493333 were found to be associated with EH significantly in stage 1 study. The association of the SNP rs140598 but not rs6493333 with EH was replicated in the remaining sample in stage 2 and metaanalysis for combined analysis. Furthermore, results of quantitative traits analysis of blood pressure between genotypes of rs140598 indicated the alteration of C>G would significantly decrease SBP rather than DBP in nontreatment patients and controls, and that further conform the genetic effect of rs140598 on hypertension.
The rs140598 C/G variant, which is located in the exon 28 of the FBN1 gene, is a missense mutation and predicts replacement of proline at FBN1 protein residue 1148 with alanine (P1148A). So, the positive association found in this study would be helpful to further research for the potential attribution of FBN1 gene function to the development of hypertension. Currently, most of previous studies mainly focused on phenotype differentiations caused by FBN1 gene knocking out instead of functional variation caused by single or multiple mutations concretely. 1, 28, 29 Here we found there was significant association of rs140598 of FBN1 gene with EH in a relatively large population for the first time. Meanwhile, several weaknesses might occur in this study. The major limitation is that limited polymorphisms in FBN1 gene were involved, and the incomplete coverage of variation probably cannot comprehensively describe the contributions of these genes. Therefore, we hope this report will stimulate studies of the FBN1 gene and hypertension that will potentially replicate our finding, either via association designs or through functional examinations.
In this study, we adopted several approaches to control potential bias. First, we included only northern Han Chinese who was ethnically homogeneous, and the subsample of the main study population has shown no population stratification by genomic control method in our previous study. 15 So the positive associations might be unlikely to be caused by population admixture and stratification. Second, the hypertensive cases with higher BP level in stage 1 were likely to be enriched genetic susceptibility and might increase power to test the association of FBN1 gene with EH. 30 Third, the ORs were adjusted for potential confounders such as age, gender, body mass index, drinking status, smoking status, glucose, and blood lipid levels. All these measures effectively reduced the false positive findings in our study.
Obviously, despite optimism that predictive valuable genotype would facilitate research for antihypertensive and benefits of using surrogate markers to gauge the effectiveness of hypertension therapy in reducing complications, 31 clinical applications of pharmacogenetic findings are still largely pending reproducible prospective investigations on the challenge to tailor pharmacologic treatment to an individual's genotype for the best possible outcome for patients. 32 Remarkably, the findings which recently have been proved to indicate biological action of FBN1 gene on vascular stiffness and plaque instability, together with positive association of FBN1 with EH raised in this study would lead more studies to the way of unraveling the underlying mechanism of EH and explore potential pharmacogenetic effects of antihypertensive medications. 27, 28, 33 In conclusion, our results suggested that the variation of rs140598 presented significant protective effect on EH and further replication in other population for association study or prospective study should be warranted.
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